Psychometric properties and validation of a four-item version of the Strauss-Carpenter scale in bipolar disorder
Autor:
Alberich, Susana
; Barbeito, Sara
; González-Ortega, Itxaso
; Ugarte, Amaia
; Vega, Patricia
; Ruiz de Azúa, Sonia
; López, Purificación
; Zorrilla, Inaki
; González-Pinto, Ana
Fecha:
10/2016Palabra clave:
Revista / editorial:
International Journal of Bipolar DisordersTipo de Ítem:
Articulo Revista IndexadaResumen:
Background: Bipolar disorder is a chronic illness that impairs functioning and affects the quality of life of patients. The onset of this illness usually occurs at an early age, and the risk of relapse remains high for decades. Thus, due to the great clinical relevance of identifying long-term predictors of functioning in bipolar disorder, Strauss and Carpenter developed a scale composed of items known to have prognostic value.
Methods: To determine the clinical usefulness of the four-item Strauss-Carpenter scale in bipolar disorder, a 1-year prospective follow-up study was carried out. The internal consistency, convergent and discriminant validity, and test-retest reliability of the scale were assessed. We also compared the Strauss-Carpenter scale with the reference scales Global Assessment Functioning (GAF), Clinical Global Impression for Bipolar Disorder, the Modified Version (CGI-BIP-M) and the Sheehan Disability Scale (Sheehan). Additionally, a cut-off point for remission was established.
Results: The total sample was composed of 98 patients with a diagnosis of bipolar disorder. The four-item version of the Strauss-Carpenter scale showed to have appropriate psychometric properties, comparable to those of reference scales. The best cut-off point for remission was 14.
Conclusions: The four-item version of the Strauss-Carpenter scale has suitable validity and reliability for the assessment of functioning in patients with bipolar disorder.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
114 |
68 |
35 |
53 |
66 |
93 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Evaluación a 2 años de un programa psicoeducativo multifamiliar (PROTEC) en la carga familiar y el pronóstico de pacientes bipolares
Barbeito, Sara; Vega, Patricia; Ruiz de Azúa, Sonia; González-Ortega, Itxaso; Alberich, Susana; González-Pinto, Ana (Ediciones Doyma, S.L., 2023)Introducción El trastorno bipolar produce una carga importante en la vida de los pacientes y sus familiares. La familia es una de las dianas para la intervención terapéutica, que se ha encontrado que se relaciona con el ... -
A multicentre, randomised, controlled trial of a combined clinical treatment for first-episode psychosis
González-Ortega, Itxaso; Vega, Patricia; Echeburúa, Enrique; Alberich, Susana; Fernández-Sevillano, Jessica; Barbeito, Sara ; Balanzá-Martínez, Vicent; Vieta, Eduard; Lorente-Rovira, Esther; Luengo, Ana; Cerrillo, Ester; Crespo, José Manuel (MDPI AG, 2021)Introduction: There is evidence that early intervention contributes to improving the prognosis and course of first-episode psychosis (FEP). However, further randomised treatment clinical trials are needed. Objectives: The ... -
A systematic review of sex-based differences in effectiveness and adverse effects of clozapine
Alberich, Susana; Fernández-Sevillano, Jessica; González-Ortega, Itxaso; Usall, Judith; Sáenz, Marga; González-Fraile, Eduardo ; González-Pinto, Ana (Psychiatry Research, 10/2019)Clozapine is one of the most widely used antipsychotics for treating psychiatric illnesses such as schizophrenia and bipolar disorder. This drug, however, is associated with adverse effects such as weight gain, metabolic ...